Department of Health
and Human Services (HHS)
and Human Services (HHS)
November 9, 2020
PAR-18-884 - Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
PAR-18-885 - Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The purpose of this Notice is to extend the expiration date for PAR-18-885, Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed).
Therefore, with the addition/extension by one Application Due Date , PAR-18-885 will now expire on December 5, 2021.
The following sections in Part 1. Overview Information, Key Dates, have been changed:
Currently reads:
Application Due Date(s): December 4, 2018, December 4, 2019, December 4, 2020, by 5:00 PM local time of applicant organization.
Scientific Merit Review: March 2019, March 2020, March 2021
Advisory Council: May 2019, May 2020, May 2021
Earliest Start Date: July 2019, July 2020, July 2021
Expiration Date: December 5, 2020
Modified to read (in italics):
Application Due Date(s): December 4, 2018, December 4, 2019, December 4, 2020, December 6, 2021 by 5:00 PM local time of applicant organization.
Scientific Merit Review: March 2019, March 2020, March 2021, March 2022
Advisory Council: May 2019, May 2020, May 2021, May 2022
Earliest Start Date: July 2019, July 2020, July 2021, July 2022
Expiration Date: December 7, 2021
All other aspects of PAR-18-885 remain unchanged.
David H. Weinberg, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-526-0349
Email: [email protected]